Page 3 - Glaxosmithkline Pharmaceuticals

GSK puts old antibiotics and UK Horlicks biz on the block

GSK is also exploring options to divest some other smaller non-core nutrition brands

GlaxoSmithKline Pharma Q3 profit dips 33 per cent at Rs 53 crore

The company had posted a net profit of Rs 78.93 crore for the same period of previous financial year

Pricing pressure in US will continue: CEO GlaxoSmithKline Plc

British drug maker GSK's global CEO Sir Andrew Witty will step down next March after eight years

Access to medicines a problem in India: Annaswamy Vaideesh, GSK India MD

Vaideesh says that the real problem is not capping of drug prices, but in the method adopted in revising prices

GlaxoSmithKline picks insider Emma Walmsley as new CEO

Her appointment is likely to be seen as a signal that GSK will retain the consumer business as a core part of its operations

GSK sells anaesthetics to Aspen for up to $370 million

Aspen is also acquiring rights to the remaining GSK thrombosis drug portfolio

GSK Pharma Q1 net down 23% at Rs 72.27 crore

Shares of the company closed 0.89% down at Rs 3,347.50 per scrip on BSE

GSK Consumer Healthcare slips after weak Q4 earnings

Opening on a weak note, the stocks further slumped 5% to Rs 5,792.

GSK Pharma to launch more combination vaccines

Combination vaccines are becoming popular as their use reduces risk of infection as well as the number of injections to be administered